MTRAX | RIREX | MTRAX / RIREX | |
Total Expense Ratio | 1.02 | 0.62 | 165% |
Annual Report Gross Expense Ratio | 1.02 | 0.62 | 165% |
Fund Existence | 30 years | 23 years | - |
Gain YTD | 6.573 | 10.384 | 63% |
Front Load | 3% | N/A | - |
Min. Initial Investment | 15000 | 250 | 6,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.03B | 114B | 1% |
Annual Yield % from dividends | 3.08 | 3.02 | 102% |
Returns for 1 year | 11.59 | 13.89 | 83% |
Returns for 3 years | 34.66 | 32.31 | 107% |
Returns for 5 years | 31.91 | 48.32 | 66% |
Returns for 10 years | 35.28 | 45.96 | 77% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
VTIP | 49.95 | 0.03 | +0.06% |
Vanguard Short-Term Infl-Prot Secs ETF | |||
SIHY | 45.24 | -0.09 | -0.20% |
Harbor Scientific Alpha High-Yield ETF | |||
MTBA | 49.78 | -0.10 | -0.20% |
Simplify MBS ETF | |||
HPS | 14.06 | -0.06 | -0.42% |
John Hancock Preferred Income Fund III | |||
HRTS | 28.81 | -0.38 | -1.30% |
Tema Obesity & Cardiometabolic ETF |